Investor Relations
Driving sustainable growth through relentless innovation. Explore our financial performance, strategic market position, and upcoming shareholder events.
Q2 2026 Financial Highlights
Allianz Medtech delivered robust second-quarter results, driven by double-digit growth in our Advanced Therapies and Digital Health software segments. Our continued disciplined execution resulted in an adjusted EBIT margin expansion of 140 basis points.
We are reaffirming our full-year guidance for fiscal 2026, anticipating comparable revenue growth between 6.5% and 8.5%, supported by a record equipment order backlog of €14.8 billion.
Download Q2 Earnings Presentation (PDF)Stock Information
ALZMED
€ 114.20
- Exchange: Frankfurt Stock Exchange (FSE)
- Market Cap: € 85.4 Billion
- Shares Outstanding: 748.2 Million
- 52-Week Range: € 92.15 - € 118.50
- Next Dividend Date: November 14, 2026
Financial Reports & Filings
Access comprehensive historical data and regulatory disclosures.
| Date | Document Type | Description | Action |
|---|---|---|---|
| August 4, 2026 | Quarterly Report | Q2 2026 Earnings Release & Financial Statements | Download PDF ↓ |
| May 10, 2026 | Quarterly Report | Q1 2026 Earnings Release & Financial Statements | Download PDF ↓ |
| February 28, 2026 | Annual Report | Annual Report 2025 (Integrated ESG Disclosures) | Download PDF ↓ |
| February 15, 2026 | Presentation | JP Morgan Healthcare Conference Deck 2026 | Download PDF ↓ |